Close
Nordic 9Nordic 9

Bio4Dreams (investor - Corporate Investor)

Italy
See something wrong or missing? Let us know
Offices:Milano
Average round investment:2.89M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: Italy ChemiCare
Mostly invests in: Italy Italy (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bio4Dreams

Name Criteria
Italy Angels4Impact
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States MassChallenge
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Oskare Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Italy Pi Campus
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Netherlands NLC Health
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Asymmetry Ventures
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Italy Ulixes
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Italy Doorway
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Italy Growth Engine
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France Advent France Biotechnology
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top